An estimated 828 million adults (420 women, 408 men) had diabetes in 2022, an increase of 630 million since 1990. India (212 ...

With the rising popularity of telehealth providers offering GLP-1 medications like Ozempic, the terminology can get confusing ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

November marks diabetes awareness month, a crucial time to focus on prevention, management, and lifestyle adjustments for the ...

With World Diabetes Day approaching, health officials stress the importance of diabetes management and introduce innovative ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Type 2 diabetes significantly elevates the risk of heart disease, making individuals more susceptible to heart attacks, strokes, and heart failure. Early management is crucial, focusing on blood sugar ...

Hamad Medical Corporation’s (HMC) Diabetes and Endocrinology Section has launched the DAFNE (Dose Adjustment for Normal Eating) structured education programme for individuals with type 1 diabetes.

Diabetes specialist Novo Nordisk is feeling the heat from increasingly price conscious US payers. It needs next generation innovation and growth in emerging markets to keep ahead of competitors ...

Novo Nordisk says an oral drug which can help type 2 diabetes patients to lower their blood sugar, substantially lower their risk of having a heart attack or stroke, and help them lose weight ...

Significant effect on acute and maximal C-peptide response at 12 weeks seen with carbohydrate-restricted diet. (HealthDay News) — A eucaloric carbohydrate-restricted (CR) diet improves β-cell ...